In this interview, we speak to Dr Christian Koch, deputy head of investment management at BB Biotech (BION), the Switzerland-based investment company listed in Switzerland, Germany and Italy. Dr Koch will assume the role of head of investment management at BB Biotech at the beginning of 2025.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

9. Bull, Bear & Beyond – BB Biotech: executive interview

HBM Healthcare Investments (SIX: HBMN) is a Swiss investment company focused on the global healthcare sector, with a particular focus on private equity and small-cap and emerging biotech companies. In this interview, we talk with the CEO, Dr Andreas Wicki, about the broader healthcare trends, the outlook for the sector and how the company’s portfolio is positioned to leverage the dynamism in the sector.

In particular, Dr Wicki outlines the rationale for the company’s leanings towards private equity and Asian markets, as well as its significant exposure to the biotech space. We discuss the main themes in the sector (with innovation as the key underlying driver), particular therapeutic areas of interest as well as the overall macroeconomic sentiment in the sector following the recent interest rate cuts by the US Federal Reserve.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

8. Bull, Bear & Beyond – HBM Healthcare Investments: executive interview

In this interview, James Smith, fund manager of Premier Miton Global Renewables Trust (PMGR), discusses the trust’s portfolio as well as the broader renewable energy sector. PMGR’s investment objectives include achieving a high income and realising long-term growth in capital value. The company invests principally in equity and equity-related securities of companies operating primarily in the renewable energy sector, as well as other similar infrastructure investments.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

7. Bull, Bear & Beyond – Premier Miton Global Renewables Trust: executive interview

In our interview with Darcy Willson-Rymer, CEO of Card Factory, we discuss the recently released H125 results, the progress the company is making on its ‘Opening Our New Future’ strategy (see our initiation note for more details) and the outlook for the rest of the year. We begin by discussing the growth drivers in retail, including the contribution from the product categories and store expansion. We also outline the progress of cardfcatory.co.uk, which has delivered two consecutive six-month periods of revenue growth and the recent developments in the company's Partnerships business. We then talk about the outlook for the year and the reasons why the phasing of expected profitability is more skewed to the second half of the year than prior years. We conclude by discussing the dividend that was declared with the interim results.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

6. Bull, Bear & Beyond – Card Factory: executive interview

The London Tunnels owns the Kingsway Exchange Tunnels in Central London and is aiming to develop a major heritage and cultural attraction, targeting full commercial launch in 2027. The company is listed on the Euronext Amsterdam.

In our first interview with The London Tunnels, Charles Nelson, independent non-executive director, introduces the company and explores the fascinating history of the tunnels. Constructed during the Blitz in World War 2, the tunnels housed the Special Operations Executive and are considered to be the inspiration for James Bond’s ‘Q Branch’. Later, they were a crucial secret government communications centre during the Cold War. Charles outlines the company’s plans to develop the site into a major tourist attraction and points to comparable attractions in London for potential financials of the business. He concludes by highlighting the next key milestones investors should look for.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

5. Bull, Bear & Beyond – The London Tunnels: executive interview

Medigene (FSE: MDG1) is a publicly listed, Germany-based, immuno-oncology platform company focused on the development of T cell receptor (TCR)-guided therapies with the aim of effectively eliminating cancer. 

In this video we speak to Dr Kirsty Crame, MD, Head of Clinical Strategy and Development at Medigene, where we cover how Medigene is differentiated within the field of precision immunotherapy, the company’s modular End-to-End Platform approach and its ongoing partnerships with BioNTech, Regeneron and, most recently, WuXi Biologics. Dr Kirsty Crame, MD, also discusses the key milestones and catalysts for investors to watch out for across the next 12–18 months.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

Original interview published on 30/09/2024 and reposted as a podcast

4. Bull, Bear & Beyond – Medigene: executive interview

AFT Pharmaceuticals (NZX: AFT) is a commercial-stage specialty pharma company with strong roots in Australasia, its own salesforce and a growing global presence through licensing and distribution agreements. 

In this interview, we speak to AFT co-founder and CEO, Dr Hartley Atkinson, about the company’s business strategy and key growth drivers as well as some of the exciting developments investors should look forward to in the next 12–18 months.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

Original interview published on 26/09/2024 and reposted as a podcast

3. Bull, Bear & Beyond – AFT Pharmaceuticals: executive interview

Regional REIT (RGL) is a specialist investor in offices across regional centres of the UK, outside the M25. It is actively managed with a strong focus on income returns. 

In this interview, Stephen Inglis, CEO of the asset manager to RGL, London & Scottish Property Investment Management, discusses in detail the company’s strategy for extracting value from the portfolio and the future balance of returns between income and capital.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

Original interview published on 25/09/2024 and reposted as a podcast

2. Bull, Bear & Beyond – Regional REIT: executive interview

IRLAB Therapeutics (OMX: IRLAB-A) is a Sweden-based biopharma company focused on the development of novel treatments for neurodegenerative diseases, with a particular focus on Parkinson’s disease (PD). The company has a highly active pipeline, with assets spanning all stages of clinical development, from preclinical programmes through to its lead asset, mesdopetam, which is Phase III-ready.

In this video we speak to Kristina Torfgård, IRLAB’s new CEO as of August 2024, and learn more about her wealth of experience in drug development, what drew her to IRLAB and her strategic priorities as the company approaches key upcoming milestones.

**************************************************************************************

About ‘Bull, Bear & Beyond’

'Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

Original interview published on 23/09/2024 and reposted as a podcast

1. Bull, Bear & Beyond: IRLAB Therapeutics – executive interview

Discover fresh perspectives in the Bull, Bear & Beyond podcast series by Edison Group. Our longer episodes feature candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation and the opportunities shaping their markets. These discussions offer unique insight into how leaders navigate challenges, drive growth and deliver long-term value for stakeholders. Our 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

To find out more, please visit: https://www.edisongroup.com/ [https://www.edisongroup.com/equities/investment-companies/]

Bull, Bear & Beyond by Edison Group